BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9637141)

  • 1. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.
    Cote RJ; Shi Y; Groshen S; Feng AC; Cordon-Cardo C; Skinner D; Lieskovosky G
    J Natl Cancer Inst; 1998 Jun; 90(12):916-20. PubMed ID: 9637141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S; Yang G; Harper JW; Lu X; Kattan MW; Thompson TC; Wheeler TM
    Mod Pathol; 1999 Aug; 12(8):751-5. PubMed ID: 10463475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
    Yang RM; Naitoh J; Murphy M; Wang HJ; Phillipson J; deKernion JB; Loda M; Reiter RE
    J Urol; 1998 Mar; 159(3):941-5. PubMed ID: 9474188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
    Thomas GV; Schrage MI; Rosenfelt L; Kim JH; Salur G; deKernion JB; Dorey F; Said J; Reiter RE
    J Urol; 2000 Dec; 164(6):1987-91. PubMed ID: 11061897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27kip1 in prostatic adenocarcinoma.
    Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
    Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
    J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
    Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
    J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
    Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
    Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
    Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
    J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of altered p27Kip1 and p21WAF/Cip1 protein expression for the clinical prognosis of patients with localized prostate cancer.
    Kuczyk MA; Bokemeyer C; Hartmann J; Schubach J; Walter C; Machtens S; Knuchel R; Kollmannsberger C; Jonas U; Serth J
    Oncol Rep; 2001; 8(6):1401-7. PubMed ID: 11605074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.
    Kuczyk M; Machtens S; Hradil K; Schubach J; Christian W; Knüchel R; Hartmann J; Bokemeyer C; Jonas U; Serth J
    Br J Cancer; 1999 Nov; 81(6):1052-8. PubMed ID: 10576664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancer.
    Ribal MJ; Fernandez PL; Lopez-Guillermo A; Farré X; Santos Y; Gibanel R; Cardesa A; Alcaraz A
    Anticancer Res; 2003; 23(6D):5101-6. PubMed ID: 14981973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
    Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
    Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen and epidermal growth factor down-regulate cyclin-dependent kinase inhibitor p27Kip1 and costimulate proliferation of MDA PCa 2a and MDA PCa 2b prostate cancer cells.
    Ye D; Mendelsohn J; Fan Z
    Clin Cancer Res; 1999 Aug; 5(8):2171-7. PubMed ID: 10473102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J; Kapusta LR; DeBoer G; Morava-Protzner I; Zbieranowski I; Bhattacharya N; Catzavelos GC; Klotz LH; Slingerland JM
    Cancer Res; 1998 Feb; 58(3):542-8. PubMed ID: 9458103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
    Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
    Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia.
    Yokozawa T; Towatari M; Iida H; Takeyama K; Tanimoto M; Kiyoi H; Motoji T; Asou N; Saito K; Takeuchi M; Kobayashi Y; Miyawaki S; Kodera Y; Ohno R; Saito H; Naoe T
    Leukemia; 2000 Jan; 14(1):28-33. PubMed ID: 10637473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.